1-10 of 10
Sunhee Ro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase Ib Study of PRT543, an Oral Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Patients with Relapsed or Refractory, Splicing Factor-Mutant Myeloid Malignancies

Jan Philipp Bewersdorf, Xiaoli Mi, Bin Lu, Andrew T. Kuykendall, David Sallman, Manish Patel, Don A. Stevens, Alexander Philipovskiy, Grerk Sutamtewagul, Lucia Masarova, Gina Keiffer, Amit Verma, Neha Bhagwat, Diane Heiser, Sunhee Ro, Wan-Jen Hong, Omar Abdel-Wahab, Eytan M. Stein
Journal: Blood
Blood (2024) 144 (Supplement 1): 3215.
https://doi.org/10.1182/blood-2024-198495
Published: 2024
Journal Articles

The Impact of Momelotinib on Patient Reported Quality of Life for Symptomatic and Anemic Patients with Myelofibrosis: Results from the Phase 3 Momentum Study

Ruben Mesa, Claire Harrison, Jeanne M. Palmer, Vikas Gupta, Donal P. McLornan, Mary Frances McMullin, Jean-Jacques Kiladjian, Lynda Foltz, Uwe Platzbecker, Maria Laura Fox, Adam J Mead, David M Ross, Stephen T Oh, Andrew Charles Perkins, Michael F. Leahy, Jun Kawashima, Sunhee Ro, Rafe Donahue, Samineh Deheshi, Srdan Verstovsek
Journal: Blood
Blood (2022) 140 (Supplement 1): 9677–9680.
https://doi.org/10.1182/blood-2022-162547
Published: 2022
Journal Articles

Baseline Serum Ferritin Differentially Predicts W24 Transfusion Independence Response for Momelotinib and Ruxolitinib in Patients with Myelofibrosis

Stephen T. Oh, Aaron T. Gerds, Ruben A. Mesa, Vikas Gupta, Mei Huang, Sunhee Ro, Bryan Strouse, Barbara Jane Klencke, Srdan Verstovsek
Journal: Blood
Blood (2021) 138 (Supplement 1): 3638.
https://doi.org/10.1182/blood-2021-146623
Published: 2021
Journal Articles

Phase 2 Study of Zanubrutinib in Patients with Relapsed/Refractory B-Cell Malignancies Intolerant to Ibrutinib/Acalabrutinib

Mazyar Shadman, MD MPH, Jeff P Sharman, MD, Moshe Y. Levy, MD, Jamal Misleh, MD, Syed F. Zafar, MD, Benjamin B. Freeman, MD, John M. Burke, MD, Jennifer L. Cultrera, MD, Habte A. Yimer, MD, Dih-Yih Chen, MD, Xiaoping Zhang, MD, Aileen Cohen, MD PhD, Sunhee Ro, PhD, Jane Huang, MD, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-134621
Published: 2020
Journal Articles

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Clinical Trials & Observations
Constantine S. Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Björn E. Wahlin, Ramón Garcia Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey V. Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Sunhee Ro, Aileen Cohen, Jane Huang, Meletios Dimopoulos
Journal: Blood
Blood (2020) 136 (18): 2038–2050.
https://doi.org/10.1182/blood.2020006844
Published: 2020
Includes: Supplemental data
Journal Articles

Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Combination with the PD-1 Inhibitor BGB-A317 in Patients with B-Cell Lymphoid Malignancies

Gavin Cull, MB, BS, FRACP, FRCPA, Stephen Opat, FRACP, FRCPA, Judith Trotman, MBChB, FRACP, FRCPA, James Hilger, Xiaoping Zhang, Shibao Feng, PhD, Sunhee Ro, PhD, Jane Huang, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4057.
https://doi.org/10.1182/blood.V130.Suppl_1.4057.4057
Published: 2017
Journal Articles

Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma

Constantine S. Tam, MBBS, MD FRACP, FRCPA, David Simpson, MBChB, Stephen Opat, FRACP, FRCPA, Won Seog Kim, MD, Ph. D., Michael Wang, MD, Gavin Cull, MB, BS, FRACP, FRCPA, Patrick B Johnston, MD PhD, Javier Munoz, MD, Won-Sik Lee, MD, Paula Marlton, MBBS, David Gottlieb, MBBS, MD FRACP, FRCPA, Lai Wang, PhD, Jane Huang, MD, James Hilger, Ling Xue, PhD, Sunhee Ro, PhD, Judith Trotman, FRACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 152.
https://doi.org/10.1182/blood.V130.Suppl_1.152.152
Published: 2017
Journal Articles

Multivariate Modelling Reveals Evidence of a Dose-Response Relationship in Phase 2 Studies of Single-Agent Carfilzomib

Pierre Squifflet, Master of Science in Statistics, Stefan Michiels, David S. Siegel, MD, PhD, Ravi Vij, MD, Sunhee Ro, Ph.D., Marc E Buyse, ScD
Journal: Blood
Blood (2011) 118 (21): 1877.
https://doi.org/10.1182/blood.V118.21.1877.1877
Published: 2011
Journal Articles

Development of a Robust and User-Friendly Method for Leukemia Classification Using Microarrays.

Wen Wei, PhD, Julie Tsai, Barbara Brady, Wei-min Liu, PhD, Xiaoying Chen, Rui Li, Sunhee Ro, PhD, James Sun, Alexander Kohlmann, PhD, Stuart Palmer, PhD, Raymond Wong, Khusbeer Malhotra, PhD, James Novotny, PhD, Mickey Williams, PhD
Journal: Blood
Blood (2006) 108 (11): 4304.
https://doi.org/10.1182/blood.V108.11.4304.4304
Published: 2006
Journal Articles

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Torsten Haferlach, MD, Alexander Kohlmann, PhD, Guiseppe Basso, PhD, Marie-Christine Bene, PhD, James R. Downing, PhD, Jesus M. Hernandez, MD, Wolf-Karsten Hofmann, MD, Thomas J. Kipps, PhD, Truus te Kronnie, PhD, Wei-Min Liu, Sunhee Ro, Elisabeth MacIntyre, PhD, Ken I. Mills, PhD, Claude Preudhomme, PhD, Laura Z. Rassenti, PhD, John de Vos, PhD, Mickey Williams, PhD, Lothar Wieczorek, Robin Foa, PhD
Journal: Blood
Blood (2005) 106 (11): 757.
https://doi.org/10.1182/blood.V106.11.757.757
Published: 2005